
Release date: 2026-07-08 11:17:28 Article From: Lucius Laos Recommended: 15
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other countries. In recent years, as Laos has increased its opening-up and introduced preferential policies, a number of pharmaceutical companies have chosen to establish factories here, and the sector has shown certain growth momentum. In 2026, Laos officially graduated from the Least Developed Country (LDC) status, and its drug registration standards have been upgraded from the WHO prequalification pathway to ICH standards, with GMP requirements raised simultaneously. The following is an overview of the main legitimate pharmaceutical manufacturers currently operating in Laos.
Lucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020 and is headquartered at No. 26, Thongmang Village, Xaythany District, Vientiane Capital, Laos. As a representative enterprise in Laos's generic drug sector, Lucius Pharmaceuticals originates from its parent company based in Hyderabad, India.
Production Scale: The factory covers an area of approximately 210,000 square meters and houses the Asia-Pacific No.1 Smart Factory, equipped with cutting-edge pharmaceutical machinery from China, the United States, Germany, and other countries, with an annual production capacity exceeding 1.5 billion tablets.
Product Portfolio: Currently produces over 200 generic drugs, covering multiple therapeutic areas including oncology, cardiovascular diseases, diabetes, hematology, dermatology, men's health, and anti-aging. As of June 2024, it has obtained marketing authorizations for 54 anti-cancer drugs, including generic versions of targeted therapies such as sotorasib, osimertinib, cabozantinib, and ivosidenib.
Certifications: Has obtained GMP certification from the Lao Ministry of Health, and its products are registered and approved by the Food and Drug Administration under the Lao Ministry of Health, granting legal production and sales qualifications. In October 2023, the World Health Organization conducted a comprehensive inspection of the Lucius Pharmaceuticals factory and confirmed that it fully complies with WHO standards.
Market Presence: Business has expanded to 12 countries including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Japan, and China.
ASEAN (Laos) Pharmaceutical and Food Co., Ltd. was established in 2012 and is the first pharmaceutical company in Laos to obtain GMP certification. The company currently holds more than 50 approved drug products, covering oncology, chronic diseases, infectious diseases, and other fields.
Element Pharma (Laos) Co., Ltd. was founded in 2019 and is located in the Boten Special Economic Zone, Laos. The company was established with the participation of the technical team from the Artificial Intelligence Bio-medical Technology Research Institute of Nanjing University in China, with a factory area of 2,500 square meters. Element Pharma focuses on the generic manufacturing, production, and sales of anti-tumor and men's health drugs, and has currently exported pharmaceutical products to more than 120 countries and regions across Asia, Africa, Europe, and Latin America.
Laos United Pharmaceutical Group was founded in 2017 as a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. It is currently the largest pharmaceutical company in Laos, accounting for approximately 27% of the domestic drug market share. The Second State Pharmaceutical Factory of Laos was established in the 1970s as a state-owned enterprise directly under the Lao Ministry of Health, producing over 160 types of drugs including infusions, injections, oral tablets, and capsules. Other players include Daewoong Pharmaceuticals, the Third Pharmaceutical Factory of Laos, and others.
Overall, the pharmaceutical industry in Laos is in a phase of rapid development. A number of legitimate manufacturers, represented by Lucius Pharmaceuticals, have formed large-scale production capabilities and have obtained official Lao GMP certifications and product registration numbers.
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other coun···【more】
Recommended:16Release date: 2026-07-08
Before 2020, there were only a handful of legally approved local pharmaceutical manufacturers in Laos, mostly small state-owned factories with outdated equipment. Within just a few···【more】
Recommended:29Release date: 2026-07-07
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern featuring coordination between state-owned and private enterprises as well as loc···【more】
Recommended:61Release date: 2026-07-02
The pharmaceutical industry in Laos started late and is limited in scale, with domestic drug supply long relying on imports of quality generic medicines from China, India and other···【more】
Recommended:240Release date: 2026-07-01
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company established in 2020, headquartered in Vientiane, the capital of Laos. Despite its short history, the company h···【more】
Recommended:92Release date: 2026-06-30
The Lao generic pharmaceutical industry has developed rapidly in recent years, attracting increasing attention from patients worldwide. As one of the least developed countries in S···【more】
Recommended:77Release date: 2026-06-29
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and···【more】
Recommended:83Release date: 2026-06-26
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of Laos was in the spotlight for its outstanding performance. Their booth attracted a large audience and···【more】
Recommended:656Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appointed by the World Health Organization (WHO) and director of the Microbiology Laboratory of the Nationa···【more】
Recommended:655Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensive inspection of the Lucius Pharmaceutical factory in Laos. The results of this assessment are encou···【more】
Recommended:794Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in the pharmaceutical industry, Lucius Pharmaceutical was established in Vientiane, Laos in 2020, with a···【more】
Recommended:587Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has state-of-the-art facilities, including factories designed and constructed in strict accordance with ···【more】
Recommended:817Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended:754Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended:715Release date: 2024-07-09
Lucius Pharmaceuticals (Lao) Co., Ltd. has launched a generic version of elagolix sodium (trade name LuciElag) for the treatment of moderate to severe pain associated with endometr···【more】
Recommended:41Release date: 2026-07-06
Contraindications for Bempedoic Acid (Nilemdo)Bempedoic acid (Nilemdo) is strictly contraindicated in the following situations: ①hypersensitivity to bempedoic acid or any excipient···【more】
Recommended:59Release date: 2026-07-03
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended:90Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended:194Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended:539Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination with abiraterone acetate (brand name: Akeega, Janssen Biotech, Inc.) plus predni···【more】
Recommended:488Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplantation (HSCT) therapy for th···【more】
Recommended:515Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (Breyanzi, developed by Juno Therapeutics, a subsidiary of Bristol Myers Squibb) ···【more】
Recommended:496Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for the treatment of adult patients with r···【more】
Recommended:557Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 study showed that for patients with HER2-positive locally advanced or metastatic ···【more】
Recommended:447Release date: 2025-12-01
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrophy (SMA), announced today its welcome for the U.S. Food and Drug Administration ···【more】
Recommended:429Release date: 2025-11-27
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued favorable opinions, proposing an amendment to the mark···【more】
Recommended:701Release date: 2025-01-13

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643